查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1307978

下一代测序 (NGS) 信息学市场：按最终用户提供、按应用 - 到 2030 年世界预测

Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS) Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 203 Pages | 订单完成后即时交付

价格

预计到 2030 年，全球 NGS 信息学市场将达到 43 亿美元，2023 年至 2030 年復合年增长率为 15.4%。

经过广泛的二次和初步研究以及对市场情景的详细分析，本报告对主要市场驱动因素、限制因素、挑战和机遇进行了分析。NGS信息学市场的增长得益于製药和生物技术公司研发投资的增加、癌症和遗传病患病率的上升、NGS在疾病诊断和精准医疗中的广泛使用以及NGS信息学解决方案的技术。进展由政府推动努力支持大规模基因组测序项目。然而，对数据隐私的担忧正在限制该市场的增长。

医院和临床实验室越来越多地采用 NGS 信息学工具，扩大使用生物信息学和基因组数据管理解决方案进行大规模数据分析和解释，预计将为 NGS 信息学市场的参与者带来增长机会。然而，缺乏操作 NGS 信息学工具所需的熟练专业人员对市场增长构成了重大挑战。

目录

第 1 章 简介

第二章研究方法论

第三章执行摘要

第四章市场洞察

    市场
  • 概述
  • 影响市场增长的因素
    • 市场动态影响分析
    • 因子分析
  • 使用案例
  • 波特五力分析
  • 下一代测序 (NGS) 信息学市场：监管分析

第五章下一代测序（NGS）信息学市场：按产品评估

  • 概述
  • 软件
    • 按类型
      • 数据分析软件
      • 数据解释和报告工具
      • 数据存储和计算工具
      • 实验室信息管理系统（LIMS）
    • 按部署方式
      • 基于网络和云
      • 本地
  • NGS信息学服务

第 6 章 下一代测序 (NGS) 信息学市场应用评估

  • 概述
  • 药物发现
  • 疾病诊断
  • 生物标誌物搜索
  • 精准医学
  • 农业和动物研究

第 7 章 最终用户的下一代测序 (NGS) 信息学市场评估

  • 概述
  • 製药和生物技术公司
  • 医院/诊断实验室
  • 学术/研究机构
  • 其他最终用户

第 8 章 下一代测序 (NGS) 信息学市场区域评估

  • 概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 其他欧洲 (RoE)
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区 (RoAPAC)
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东/非洲

第 9 章 竞争分析

  • 概述
  • 主要增长战略
  • 竞争标桿
  • 市场份额分析（2022 年）
    • Illumina, Inc.（U.S.）
    • Qiagen N.V.（Netherlands）
    • Thermo Fisher Scientific Inc.（U.S.）
    • Agilent Technologies, Inc.（U.S.）
    • F. Hoffmann-La Roche Ltd（Switzerland）
  • 供应商仪表板
    • 行业领导者
    • 市场差异化因素
    • 龙头企业
    • 启动

第十章 公司简介（业务概况、财务概况、产品组合、前五名公司SWOT分析、战略发展）

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • DNAnexus, Inc.
  • Partek Incorporated
  • Fabric Genomics, Inc.
  • DNASTAR, Inc.
  • Sapio Sciences, LLC

第十一章附录

The global NGS informatics market is projected to reach $4.3 billion by 2030, at a CAGR of 15.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the NGS informatics market is driven by increasing R&D investments by pharmaceutical and biotechnology companies, the rising prevalence of cancer and genetic disorders, the growing utilization of NGS in disease diagnostics and precision medicine, technological advancements in NGS informatics solutions, and government initiatives supporting large-scale genomic sequencing projects. However, data confidentiality concerns restrain the growth of this market.

The increasing adoption of NGS informatics tools among hospitals and clinical laboratories and the growing use of bioinformatics and genomic data management solutions for large-scale data analysis and interpretation are expected to create growth opportunities for the players operating in the NGS informatics market. However, the lack of skilled professionals required to operate NGS Informatics tools is a major challenge for market growth.

Based on offering, in 2023, the software segment is expected to account for the largest share of the market. NGS informatics software enables researchers to efficiently analyze, store, and securely share vast amounts of genomic data. With their cost and time-saving capabilities, robust data security measures, and seamless collaboration features, these software solutions enable effective genomic data management, contributing to the large market share of this segment.

Based on application, in 2023, the drug discovery segment is expected to account for the largest share of the market. The growth of this segment is driven by the benefits offered by NGS technology in drug discovery. NGS enables the identification of novel drug targets and the development of therapeutic techniques that target specific genes and proteins, including targeted therapies, gene therapy, and oligonucleotide therapy.

Based on end user, in 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the next generation sequencing (NGS) informatics market. Pharmaceutical & biotechnology companies extensively utilize NGS for high-throughput analysis and genetic-based drug development. The adoption of NGS informatics has enabled efficient management, analysis, and reporting of large volumes of genomic data, thereby supporting remote work and enhancing research capabilities. These factors contribute to the significant market share of this segment.

An in-depth analysis of the geographical scenario of the global NGS informatics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the NGS informatics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The factors supporting the largest share of this market are technological advancements in the region, the increasing prevalence of cancer, and increased healthcare care spending. Additionally, the presence of key players, well-established healthcare infrastructure, and government initiatives for NGS-based diagnostic testing also contribute to the large market share of North America.

The key players operating in the global NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).

Scope of the Report:

Next Generation Sequencing (NGS) Informatics Market Assessment-by Offering

  • Software
    • By Type,
  • Data Analysis Software
  • Data Interpretation and Reporting Tools
  • Data Storage and Computing Tools
  • Laboratory Information Management Systems (LIMS)
    • By Deployment mode,
  • Web and Cloud-based
  • On-premise
  • NGS Informatics Services

Next Generation Sequencing (NGS) Informatics Market Assessment-by Application

  • Disease Diagnoses
  • Biomarker Discovery
  • Drug Discovery
  • Precision Medicine
  • Agriculture and Animal Research

Next Generation Sequencing (NGS) Informatics Market Assessment-by End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Other End Users

Note: Other end users include forensic laboratories & security agencies, food and beverage companies, and agriculture companies.

Next Generation Sequencing (NGS) Informatics Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitation
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
  • 2.3. Market Sizing and forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Use Cases
    • 4.3.1. Use Case A
    • 4.3.2. Use Case B
    • 4.3.3. Use Case C
    • 4.3.4. Use Case D
    • 4.3.5. Use Case E
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Buyers
    • 4.4.2. Bargaining Power of Suppliers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Next-Generation Sequencing (NGS) Informatics Market: Regulatory Analysis

5. Next Generation Sequencing (NGS) Informatics Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Software
    • 5.2.1. By Type
      • 5.2.1.1. Data Analysis Software
      • 5.2.1.2. Data Interpretation and Reporting Tools
      • 5.2.1.3. Data Storage and Computing Tools
      • 5.2.1.4. Laboratory Information Management Systems (LIMS)
    • 5.2.2. By Deployment Mode
      • 5.2.2.1. Web and Cloud-Based
      • 5.2.2.2. On-Premise
  • 5.3. NGS Informatics Services

6. Next-Generation Sequencing (NGS) Informatics Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Drug Discovery
  • 6.3. Disease Diagnoses
  • 6.4. Biomarker Discovery
  • 6.5. Precision Medicine
  • 6.6. Agriculture and Animal Research

7. Next-Generation Sequencing (NGS) Informatics Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical & Biotechnology Companies
  • 7.3. Hospitals & Diagnostic Laboratories
  • 7.4. Academic & Research Institutes
  • 7.5. Other End Users

8. Next-Generation Sequencing Informatics (NGS) Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (RoE)
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific (RoAPAC)
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Market Share Analysis (2022)
    • 9.4.1. Illumina, Inc. (U.S.)
    • 9.4.2. Qiagen N.V. (Netherlands)
    • 9.4.3. Thermo Fisher Scientific Inc. (U.S.)
    • 9.4.4. Agilent Technologies, Inc. (U.S.)
    • 9.4.5. F. Hoffmann-La Roche Ltd (Switzerland)
  • 9.5. Vendor Dashboard
    • 9.5.1. Industry Leaders
    • 9.5.2. Market Differentiators
    • 9.5.3. Vanguards
    • 9.5.4. Emerging Companies

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, SWOT Analysis of Top 5 Companies, and Strategic Developments)

  • 10.1. Thermo Fisher Scientific, Inc.
  • 10.2. Illumina, Inc.
  • 10.3. QIAGEN N.V.
  • 10.4. F. Hoffmann-La Roche Ltd
  • 10.5. Agilent Technologies, Inc.
  • 10.6. DNAnexus, Inc.
  • 10.7. Partek Incorporated
  • 10.8. Fabric Genomics, Inc.
  • 10.9. DNASTAR, Inc.
  • 10.10. Sapio Sciences, LLC

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports

List of Tables

  • Table 1 Global NGS Informatics Market: Impact Analysis of Market Dynamics (2023-2030)
  • Table 2 Estimated Number of New Cancer Cases, by Type (2020 VS. 2030)
  • Table 3 Common Genetic Disorders: Rates of Occurrence
  • Table 4 NGS Informatics: Standards and Compliance Guidelines
  • Table 5 Global NGS Informatics Market, by Offering, 2021-2030 (USD Million)
  • Table 6 Global NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 7 Global NGS Informatics Software Market, by Country/Region, 2021-2030 (USD Million)
  • Table 8 Global NGS Data Analysis Software Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global NGS Data Interpretation and Reporting Tools Market, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Global NGS Data Storage and Computing Tools Market, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global NGS Laboratory Information Management Systems (LIMS) Market by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 13 Global Web and Cloud-Based NGS Informatics Software Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global On-premise NGS Informatics Software Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global NGS Informatics Services Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 17 Global NGS Informatics Market for Drug Discovery, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global NGS Informatics Market for Disease Diagnoses, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Currently Available Targeted Therapies and Corresponding Biomarkers
  • Table 20 Global NGS Informatics Market for Biomarker Discovery, by Country/Region, 2021-2030 (USD Million)
  • Table 21 Global NGS Informatics Market for Precision Medicine, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global NGS Informatics Market for Agriculture & Animal Research, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 24 Global NGS Informatics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
  • Table 25 Global NGS Informatics Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Global NGS Informatics Market for Academic & Research Institutes, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Global NGS Informatics Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 28 Global NGS Informatics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 29 North America: NGS Informatics Market, by Country, 2021-2030 (USD Million)
  • Table 30 North America: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 31 North America: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 32 North America: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 33 North America: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 34 North America: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 35 U.S.: Key Macro & Microindicators
  • Table 36 U.S.: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 37 U.S.: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 38 U.S.: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 39 U.S.: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 40 U.S.: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 41 Canada: Key Macro & Micro Indicators
  • Table 42 Canada: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 43 Canada: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 44 Canada: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 45 Canada: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 46 Canada: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 47 Europe: NGS Informatics Market, by Country, 2021-2030 (USD Million)
  • Table 48 Europe: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 49 Europe: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 50 Europe: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 51 Europe: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 52 Europe: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 53 Germany: Key Macro & Micro Indicators
  • Table 54 Germany: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 55 Germany: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 56 Germany: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 57 Germany: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 58 Germany: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 59 France: Key Macro & Indicators
  • Table 60 France: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 61 France: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 62 France: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 63 France: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 64 France: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 65 U.K.: Key Macro & Micro Indicators
  • Table 66 U.K.: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 67 U.K.: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 68 U.K.: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 69 U.K.: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 70 U.K.: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 71 Italy: Key Macro & Micro Indicators
  • Table 72 Italy: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 73 Italy: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 74 Italy: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 75 Italy: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 76 Italy: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 77 Spain: Key Macro & Micro Indicators
  • Table 78 Spain: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 79 Spain: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 80 Spain: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 81 Spain: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 82 Spain: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 83 Estimated Number of New Cancer Cases, by Country, 2020 VS. 2030
  • Table 84 Rest of Europe: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 85 Rest of Europe: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 86 Rest of Europe: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 87 Rest of Europe: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 88 Rest of Europe: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 89 Asia-Pacific: NGS Informatics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 90 Asia-Pacific: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 91 Asia-Pacific: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 92 Asia-Pacific: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 93 Asia-Pacific: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 94 Asia-Pacific: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 95 China: Key Macro & Micro Indicators
  • Table 96 China: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 97 China: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 98 China: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 99 China: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 100 China: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 101 Japan: Key Macro & Micro Indicators
  • Table 102 Japan: NGS Informatics Market, by Offering, 2021-2030 (USD Million)
  • Table 103 Japan: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 104 Japan: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 105 Japan: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 106 Japan: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 107 India: Key Macro & Micro Indicators
  • Table 108 India: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 109 India: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 110 India: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 111 India: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 112 India: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 113 Estimated Number of New Cancer Cases, by Country, 2020 VS. 2030
  • Table 114 Rest of Asia-Pacific: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 115 Rest of Asia-Pacific: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 116 Rest of Asia-Pacific: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 117 Rest of Asia-Pacific: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 118 Rest of Asia-Pacific: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 119 Latin America: NGS Informatics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 120 Latin America: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 121 Latin America: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 122 Latin America: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 123 Latin America: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 124 Latin America: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 125 Brazil: Key Macro & Micro Indicators
  • Table 126 Brazil: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 127 Brazil: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 128 Brazil: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 129 Brazil: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 130 Brazil: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 131 Mexico: Key Macro & Micro Indicators
  • Table 132 Mexico: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 133 Mexico: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 134 Mexico: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 135 Mexico: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 136 Mexico: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 137 Rest of Latin America: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 138 Rest of Latin America: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 139 Rest of Latin America: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 140 Rest of Latin America: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 141 Rest of Latin America: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 142 Middle East & Africa: NGS Informatics Market, by Offering , 2021-2030 (USD Million)
  • Table 143 Middle East & Africa: NGS Informatics Software Market, by Type, 2021-2030 (USD Million)
  • Table 144 Middle East & Africa: NGS Informatics Software Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 145 Middle East & Africa: NGS Informatics Market, by Application, 2021-2030 (USD Million)
  • Table 146 Middle East & Africa: NGS Informatics Market, by End User, 2021-2030 (USD Million)
  • Table 147 Recent Developments, by Company, 2020-2023

List of Figures

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global NGS Informatics Market, by Offering , 2023 VS. 2030 (USD Million)
  • Figure 8 Global NGS Informatics Software Market, by Deployment Mode, 2023 VS. 2030 (USD Million)
  • Figure 9 Global NGS Informatics Market, by Application, 2023 VS. 2030 (USD Million)
  • Figure 10 Global NGS Informatics Market, by End User, 2023 VS. 2030 (USD Million)
  • Figure 11 Global NGS Informatics Market Shares, by Geography, 2023
  • Figure 12 Pharmaceutical R&D Expenditures in the U.S., Europe, and China, 2010 VS. 2019 VS. 2020 (USD Million)
  • Figure 13 Global Pharmaceutical R&D Expenditure, 2012-2026 (USD Billion)
  • Figure 14 Porter's Five Forces Analysis
  • Figure 15 Global NGS Informatics Market, by offering , 2023 VS. 2030 (USD Million)
  • Figure 16 Global NGS Informatics Software Market, by Deployment Mode, 2023 VS. 2030 (USD Million)
  • Figure 17 Global NGS Informatics Market, by Application, 2023 VS. 2030 (USD Million)
  • Figure 18 Estimated Number of New Cancer Cases (In Million)
  • Figure 19 Percentage of FDA Approvals for Personalized Medicine, 2015-2021
  • Figure 20 Global NGS Informatics Market, by End User, 2023 VS. 2030 (USD Million)
  • Figure 21 Global Pharmaceutical R&D Spending, 2014-2028 (USD Billion)
  • Figure 22 Global NGS Informatics Market, by Geography, 2023 VS. 2030 (USD Million)
  • Figure 23 North America: NGS Informatics Market Snapshot
  • Figure 24 U.S.: Pharmaceutical R&D Expenditure, 2014-2021 (USD Billion)
  • Figure 25 Europe: Pharmaceutical Industry R&D Expenditure (2000-2021)
  • Figure 26 Europe: NGS Informatics Market Snapshot
  • Figure 27 Italy: Number of Biotechnology Firms, 2010-2021
  • Figure 28 RoE: Pharmaceutical R&D Expenditure, 2020
  • Figure 29 Asia-Pacific: NGS Informatics Market Snapshot
  • Figure 30 Latin America: NGS Informatics Market Snapshot
  • Figure 31 Key Growth Strategies Adopted by Leading Players (2020-2023)
  • Figure 32 Next Generation Sequencing (NGS) Informatics Market: Competitive Benchmarking, by Offering
  • Figure 33 Next Generation Sequencing (NGS) Informatics Market: Competitive Benchmarking, by Region
  • Figure 34 Global Next Generation Sequencing (NGS) Informatics Market Share Analysis, by Key Players, 2022 (%)
  • Figure 35 Vendor Dashboard: Next Generation Sequencing (NGS) Informatics Market
  • Figure 36 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
  • Figure 37 Illumina, Inc.: Financial Overview (2022)
  • Figure 38 QIAGEN N.V.: Financial Overview (2022)
  • Figure 39 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
  • Figure 40 Agilent Technologies, Inc.: Financial Overview (2022)